News
October 2024 — Dr. Alireza Falahati, a leading endocrinologist and Founder of Utah Endocrinology Associates, began the first day of his academic exchange at Sun Yat-sen University Cancer Center’s Ultrasound Department in Guangzhou, China. The visit included observing three live...
Continue reading
Baird Medical successfully listed on NASDAQ, marking a major milestone in its growth as a global leader in microwave ablation technology. This listing enhances Baird Medical’s visibility in the international healthcare market, supporting the company’s mission to advance minimally invasive treatment options for patients worldwide.
Continue reading
Microwave Ablation (MWA) has emerged as a superior alternative to Radiofrequency Ablation (RFA) for the treatment of thyroid nodules, particularly in cases involving highly vascular tissue. This case study presents a comparative analysis of both techniques, highlighting MWA’s advantages in...
Continue reading
September 30, 2024 — For many years, thyroid cancer treatment has been primarily focused on traditional surgical procedures like thyroidectomy, which involves the partial or complete removal of the thyroid gland. While effective, these surgeries can leave patients dependent on...
Continue reading
September 2024 — Over the past five months, Baird Medical has facilitated five collaborative meetings between leading doctors from China and the United States to discuss the clinical value of microwave ablation (MWA) technology in thyroid treatments. These meetings, hosted...
Continue reading